Update on non-typeable Haemophilus influenzae-mediated disease and vaccine development

Research output: Contribution to journalReviewResearchpeer-review

Standard

Update on non-typeable Haemophilus influenzae-mediated disease and vaccine development. / Jalalvand, Farshid; Riesbeck, Kristian.

In: Expert Review of Vaccines, Vol. 17, No. 6, 03.06.2018, p. 503-512.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Jalalvand, F & Riesbeck, K 2018, 'Update on non-typeable Haemophilus influenzae-mediated disease and vaccine development', Expert Review of Vaccines, vol. 17, no. 6, pp. 503-512. https://doi.org/10.1080/14760584.2018.1484286

APA

Jalalvand, F., & Riesbeck, K. (2018). Update on non-typeable Haemophilus influenzae-mediated disease and vaccine development. Expert Review of Vaccines, 17(6), 503-512. https://doi.org/10.1080/14760584.2018.1484286

Vancouver

Jalalvand F, Riesbeck K. Update on non-typeable Haemophilus influenzae-mediated disease and vaccine development. Expert Review of Vaccines. 2018 Jun 3;17(6):503-512. https://doi.org/10.1080/14760584.2018.1484286

Author

Jalalvand, Farshid ; Riesbeck, Kristian. / Update on non-typeable Haemophilus influenzae-mediated disease and vaccine development. In: Expert Review of Vaccines. 2018 ; Vol. 17, No. 6. pp. 503-512.

Bibtex

@article{5aa91ca693bc487db7ba082c30e4101b,
title = "Update on non-typeable Haemophilus influenzae-mediated disease and vaccine development",
keywords = "Acute otitis media, AOM, chronic obstructive pulmonary disease, COPD, Moraxella catarrhalis, non-typeable Haemophilus influenzae, protein-based vaccine, Streptococcus pneumoniae",
author = "Farshid Jalalvand and Kristian Riesbeck",
year = "2018",
month = jun,
day = "3",
doi = "10.1080/14760584.2018.1484286",
language = "English",
volume = "17",
pages = "503--512",
journal = "Expert Review of Vaccines",
issn = "1476-0584",
publisher = "Taylor & Francis",
number = "6",

}

RIS

TY - JOUR

T1 - Update on non-typeable Haemophilus influenzae-mediated disease and vaccine development

AU - Jalalvand, Farshid

AU - Riesbeck, Kristian

PY - 2018/6/3

Y1 - 2018/6/3

KW - Acute otitis media

KW - AOM

KW - chronic obstructive pulmonary disease

KW - COPD

KW - Moraxella catarrhalis

KW - non-typeable Haemophilus influenzae

KW - protein-based vaccine

KW - Streptococcus pneumoniae

U2 - 10.1080/14760584.2018.1484286

DO - 10.1080/14760584.2018.1484286

M3 - Review

C2 - 29863956

VL - 17

SP - 503

EP - 512

JO - Expert Review of Vaccines

JF - Expert Review of Vaccines

SN - 1476-0584

IS - 6

ER -

ID: 202229238